Replies to post #3165 on Biotech Values

[zebra4o1]

Dew, Is this Avastin warning serious, or a non-event?

[DewDiligence]

>> do you think GTCB's compound could eventually treat other thromboembolic events, such as the one's mentioned above in the new [Avastin] label? <<

GTCB’s ATryn is intended to be a replacement for natural antithrombin in patients who are deficient. ATryn has several potential indications (such as burns), but it is not intended to be a general-purpose anti-thrombotic.